Nazaret Gamez
Houston Methodist Research InstituteHouston, United States
331397 RESULTS
Houston Methodist Research InstituteHouston, United States
Alchemab Therapeutics
COMMENT It is wonderful to see a treatment strategy, proposed by my collaborators and me in 2002 in publications describing the neuroprotective/neurotrophic actions of GLP-1 receptor agonists, demonstrating efficacy in Parkinson’s disease (Perry et al., 2002; Per
PAPER Chang CW, Tan CH, Hong WP, Yu RL
PAPER Cevik SE, Skaar DA, Jima DD, Liu AJ, Østbye T, Whitson HE, Jirtle RL, Hoyo C, Planchart A
PAPER Soyer A, Goutal S, Leterrier S, Marie S, Larrat B, Selingue E, Winkeler A, Sarazin M, Bottlaender M, Tournier N
PAPER Ma Z, Zhang Z, Lv X, Zhang H, Lu K, Su G, Huang B, Chen H
PAPER Srivastava A, Kumar G, Kumar P, Srikrishna S, Chandra P, Singh VP
PAPER Zaafar D, Elghazawy NH, Hassan A, Mahmoud MY, Bakr AF, Arafa RK
PAPER Mey M, Bhatta S, Suresh S, Labrador LM, Piontkivska H, Casadesus G
PAPER Ikeda K, Sugiura Y, Nakao H, Nakano M
PAPER Pilotto A, Carini M, Lupini A, di Fonzo A, Monti E, Bresciani R, Padovani A, Biasiotto G
PAPER Li Y, Munoz-Mayorga D, Nie Y, Kang N, Tao Y, Lagerwall J, Pernaci C, Curtin G, Coufal NG, Mertens J, Shi L, Chen X
PAPER Qian Z, Wang Z, Li B, Meng X, Kuang Z, Li Y, Yang Y, Ye K
PAPER Wang BY, Liu SY, Hao KM, Qi WX
No filters selected